NCT06378047 2026-02-09
Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
Clinical Trials
13 trialsNCT03484299 2025-10-29
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
University of Louisville
Phase 1 Recruiting
NCT06205849 2025-07-25
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
University of California, San Diego
Phase 1 Recruiting
NCT05435053 2023-09-15
CHECKPOINT
Zealand University Hospital
Phase 2 Terminated
NCT01939665 2022-12-20
PANFIRE
Amsterdam UMC, location VUmc
Phase 1/2 Completed
NCT02791503 2022-12-20
CROSSFIRE
Amsterdam UMC, location VUmc
Phase NA Completed
NCT04612530 2022-12-20
PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer
Amsterdam UMC, location VUmc
Phase 1 Unknown
NCT04835402 2022-03-09
EPIC-1
Aalborg University Hospital
Phase 2 Unknown
NCT02981719 2021-01-22
Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT03180437 2020-11-02
Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02841436 2020-07-07
A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer
National Taiwan University Hospital
Phase NA Completed
NCT04310553 2020-03-17
An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined With Radiotherapy and Chemotherapy in Patients With Locally Advanced Pancreatic Cancer
RenJi Hospital
Phase NA Unknown
NCT02718859 2019-09-12
Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed